Keywords: Intermittent therapy; Patient centered treatment; Adherence; Qualitative study; ICS; inhaled corticosteroids; SBA; symptom based adjustment; LTRA; leukotriene receptor antagonist; LABA; long acting beta agonist;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Asthma; Allergic asthma; Elderly; Aeroallergens; Atopy; IgE; Asthma-COPD overlap syndrome (ACOS); Age of asthma onset; ACOS; Asthma-COPD overlap syndrome; AERD; Aspirin-exacerbated respiratory disease; BMI; Body mass index; COPD; Chronic obstructive pulmo
Keywords: Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: Asthma; overweight; obesity; children; infants; exacerbation; AD; Asthma symptom days; BMI; Body mass index; ED; Emergency department; ICS; Inhaled corticosteroids; INFANT; Individualized Therapy for Asthma in Toddlers; LTRA; Leukotriene receptor antagoni
Keywords: Asthma; Elderly people; Asthma phenotypes; Asthma medications; Drug claims data; ACO; Asthma-COPD overlap; AQLQ; Asthma Quality of Life Questionnaire; ATC; Anatomical Therapeutic Chemical; BMI; Body mass index; CI; Confidence interval; COPD; Chronic obstr
Keywords: acute; antihistamines; children; chronic; corticosteroids; elderly; leukotriene receptor antagonists; management; omalizumab; quality of life; urticaria; ASST; autologous serum skin test; AU; acute urticaria; BB-UVB; broadband ultraviolet B; CSU; chronic
Keywords: Asthma; obesity; inhaled corticosteroid monotherapy; inhaled corticosteroid combination therapy; marginal structural Cox model; BMI; Body mass index; HFA-BDPeq; Hydrofluroalkane-propelled beclomethasone dipropionate or equivalent; HR; Hazard ratio; ICD-9/
Keywords: AHI; apnoea hypopnea index; BMI; body mass index; IL; interleukin; LMI; leg movement index; LOS; length of stay; LTRA; leukotriene antagonist; OSA; obstructive sleep apnoea; OAHI; obstructive apnoea-hypopnea index; OR; odds ratio; NREM; non-rapid eye mo
Keywords: ACT; asthma control test; AQLQ; asthma quality of life questionnaire; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in the first second; GINA; global initiative for asthma; HRQoL; health related quality of life; ICS; inhaled
Keywords: Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: Asthma; Children; Controller medications; Adherence; Provider; ED; emergency department; HPHC; Harvard Pilgrim Health Care; ICS; inhaled corticosteroids; ICS/LABA; inhaled corticosteroids/long-acting beta-agonist; LTRA; leukotriene antagonist; OR; odds ra
Keywords: Exhaled nitric oxide; blood eosinophil count; asthma control; lung function; bronchial responsiveness; ACT; Asthma Control Test; ATS; American Thoracic Society; BHR; Bronchial hyperresponsiveness; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital
Keywords: AED; Accident and Emergency Department; aYPFS; augmented Yu Ping Feng San; ACT; Asthma Control Test; cACT; Childhood Asthma Control Test; CAM; complementary and alternative medicines; FEF50; forced expiratory flow at 50% of FVC; FEV1; forced expiratory vo
Keywords: Asthma; Phenotype; Persistent airflow obstruction; Airways inflammation; Cluster analysis; ANOVA; analysis of variance; ATS; American Thoracic Society; BHR; bronchial hyperresponsiveness; BMI; body mass index; COPD; chronic obstructive pulmonary disease;
Keywords: Chronic urticaria; Hives; Patient-specific clinical characteristics; Treatment selection; Control; Physical urticaria; Dermatographism; Medications; CU; Chronic urticaria; JTFPP; Joint Task Force Practice Parameter; LTRA; Leukotriene receptor antagonist;
Keywords: Asthma; Resource use; Outcomes; Comparative effectiveness; Propensity score; Treatment; ANCOVA; analysis of covariance; B/F; budesonide + formoterol; CI; confidence interval; F/S; fluticasone + salmeterol; ICD; international classification of diseases
Keywords: Omalizumab; Urticaria; Chronic spontaneous; Chronic idiopathic; Itch; Hive; Pruritus; Wheal; Antihistamine; AE; Adverse event; CI; Confidence interval; CIU; Chronic idiopathic urticaria; CSU; Chronic spontaneous urticaria; CU; Chronic urticaria; DLQI; Der
Keywords: Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-adrenergic agonists; personalized medicine; severe
Keywords: Asthma; asthma control; quality of life; network meta-analysis; questionnaire; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist;
Keywords: Asthma; Lung function; Macrolide; Meta-analysis; CNKI; China national knowledge internet; WMD; weighed mean difference; SMD; standardized mean difference; PEF; peak expiratory flow; AHR; airway hyper-responsiveness; FEV1/FVC; the ratio of forced expirator
Keywords: ADAM; A Disintegrin And Metalloprotease Domain; AHR; airway hyperreponsiveness; Ang; angiopoietin; ASM; airway smooth muscle; BALf; bronchoalveolar lavage fluid; bFGF; basic fibroblast growth factor; BM; basement membrane; Col; collagen; CTGF; connective
Keywords: ED; Emergency department; HEDIS; Healthcare Effectiveness Data and Information Set; ICD-9; International Classification of Diseases, 9th revision; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; LTRAM; Leukotriene receptor antagonist m
Keywords: Asthma; Controller medications; Effectiveness; Inhaled corticosteroids; Leukotriene antagonist; Long-acting β-agonist; ED; Emergency department; hdPS; High-dimensional propensity score; HPHC; Harvard Pilgrim Health Care; HR; Hazard ratio; ICS; Inhaled co
Keywords: Asthma; Anti-asthmatic agents; Step down; Withdraw; Discontinue; Decrease; Wean; Cessation; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; RCT; Randomized controlled trial;
Keywords: asthma; Severe asthma; Asthma control; Asthma management; Prescription data; ACE; Angiotensin-converting-enzyme; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; GP; General practitioner; ICS; Inhaled corticosteroid; ICS-LABA; Fixed-
Keywords: Pediatrics; Asthma; Physician training; Inhaled corticosteroids; Spirometry; %FEV1; Percentage predicted FEV1; BMI; Body mass index; CT; Computed tomography; CXR; Chest radiography; ED; Emergency department; FVC; Forced vital capacity; GERD; Gastroesophag
Keywords: Asthma; Comparative effectiveness; Retrospective cohort study; Inhaled corticosteroids; Long-acting β2-adrenergic agonist; short-acting β2-adrenergic-agonists; Budesonide-formoterol combination; Fluticasone-salmeterol combination; BFC; Budesonide-form
Keywords: Chronic idiopathic urticaria; chronic spontaneous urticaria; H1-antihistamine; H2-antihistamines; hive; itch; leukotriene receptor antagonist; omalizumab; pruritus; wheal; AE; Adverse event; CIU/CSU; Chronic idiopathic urticaria/chronic spontaneous urtica
Keywords: AA; arachidonic acid; COX; cyclooxygenase; EDTA; ethylenediaminetetraacetate; ESI; electrospray ionization; fMLP; formyl-methionyl-leucyl-phenylalanine; 12-HHT; 12(S)-hydroxy-5-cis-8,10-trans-heptadecatrienoic acid; 5-H(P)ETE; 5(S)-hydro(pero)xy-6-trans-8
Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies
Keywords: AA; arachidonic acid; CV; Cardiovascular; CysLTs; cysteinyl leukotrienes; CysLTR; cysteinyl leukotrienes receptor; LT; leukotrienes; LTRA; leukotrienes receptor antagonist; Leukotriene receptor antagonist; Montelukast; Cardiovascular event; Cysteinyl leuk
The Tempest: Difficult to Control Asthma in Adolescence
Keywords: Severe asthma; Adolescent; Phenotype; Biologics; Difficult-to-treat asthma; Adherence; Psychosocial; ACT; Asthma Control Test; ATS; American Thoracic Society; BT; bronchial thermoplasty; ERS; European Respiratory Society; FDA; Food and Drug Administration
The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling
Keywords: Asthma; Remodeling; Animal model; TGF-β signaling; LTRA;
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Keywords: Asthma; Child; Inhaled corticosteroid; Long-acting β-agonist; Step-up therapy; aOR; Adjusted odds ratio; aRR; Adjusted rate ratio; BDP; Beclomethasone dipropionate; BTS/SIGN; The British Thoracic Society and Scottish Intercollegiate Guidelines Network; C
The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps
Keywords: CRSw/sNP; chronic rhinosinusitis with/without nasal polyp; IL; interleukin; KCN; key cytokines negative; CysLT; cysteinyl leukotriene; CYSLTR; cysteinyl leukotriene receptor; LTRA; leukotriene receptor antagonist; FESS; functional endoscopic sinus surgery
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
Keywords: Anticholinergic drug; asthma; asthma control; children; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-IA; Interviewer-administered Asthma Control Questionnaire; FEF25-75; Forced expiratory flow at 25% to 75% of the forced vital capacity
Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment
Keywords: Adrenergic receptors; asthma; child; disease exacerbation; therapeutics; ADRB2; β2-Adrenoceptor gene; GALA II; Genes-Environments and Admixture in Latino Americans; HWE; Hardy-Weinberg equilibrium; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonis
Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?
Keywords: Allergic rhinitis; Oral antihistamine; Intranasal antihistamine; Intranasal corticosteroid; Leukotriene receptor antagonist; Minimal clinically important difference (MCID); Seasonal allergic rhinitis (SAR); Total nasal symptom score (TNSS); AHRQ; Agency f
Tiotropium add-on therapy in adolescents with moderate asthma: AÂ 1-year randomized controlled trial
Keywords: Adolescent; anticholinergic drug; asthma; asthma control; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-6; 6-question Asthma Control Questionnaire; ACQ-7; 7-question Asthma Control Questionnaire; AQLQ(S)+12; Asthma Quality of Life Quest
Phenotypic and genotypic association of epithelial IL1RL1Â to human TH2-like asthma
Keywords: Asthma; IL1RL1; ST2L; sST2; TH2 inflammation; single nucleotide polymorphisms; AEC; 3-Amino-9-ethylcarbazole; ALI; Air-liquid interface; ATS; American Thoracic Society; BAL; Bronchoalveolar lavage; BMI; Body mass index; CLCA1; Calcium-activated chloride c
Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes
Keywords: Leukotriene D4; methacholine; bronchial provocation test; asthma; leukotriene responsive; leukotriene unresponsive; control status; AUC; Area under the curve; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; LTD4; Leukotriene D4; LTD4-BPT; LTD4 br
Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome
Keywords: Antineutrophil cytoplasmic autoantibodies; Churg-Strauss syndrome; clinical features; US Food and Drug Administration's Adverse Event Reporting System database; myeloperoxidase; AERS; Adverse Event Reporting System; ANCA; Antineutrophil cytoplasmic autoan
Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
Keywords: Atherosclerosis; inflammation; myocardial infarction; pharmacoepidemiology; stroke; ACE; Angiotensin-converting enzyme; ATC; Anatomical Therapeutical Chemical; COPD; Chronic obstructive pulmonary disease; CysLT; Cysteinyl leukotriene; HR; Hazard ratio; IC
(Ex-)smoking asthma patients in general and specialized Belgian practice
Keywords: Non-smoking asthma patients; (Ex-)smoking asthma patients; COPD; Asthma; ANS; non-smoking asthma patients; AS; (ex-)smoking asthma patient; COPD; chronic obstructive pulmonary disease; FCT; fixed combination treatment; GINA; global initiative for asthma;
Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy
Keywords: CAMP; Childhood Asthma Management Program; EPR-3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; mAPI; Modified Asthma Predictive Index;
Eoxins: AÂ new inflammatory pathway in childhood asthma
Keywords: Exhaled breath condensate; leukotrienes; 15-hydroxyeicosatetraenoic acid; eoxins; asthma; child; BAL; Bronchoalveolar lavage; BHR; Bronchial hyperresponsiveness; BMI; Body mass index; CysLT; Cysteinyl leukotriene; EBC; Exhaled breath condensate; ECP; Eosi
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing
Keywords: Wheezing; preschool children; montelukast; budesonide; API; Asthma predictive index; AUC; Area under the curve; CARE; Childhood Asthma Research and Education; EFD; Episode-free day; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; RTI;
Severe intermittent wheezing in preschool children: A distinct phenotype
Keywords: Childhood asthma; wheezing; intermittent asthma; AIMS; Acute Intervention Management Strategies; API; Asthma Predictive Index; CARE; Childhood Asthma Research and Education Network; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; RTI;
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation
Keywords: Anti-inflammatory effects; anti-IgE; asthma; atopic dermatitis; β2-agonist; eosinophilic inflammation; inflammatory mediators; inhaled corticosteroids; leukotriene receptor antagonist; paradigm shift; small airways; systemic inflammation; rhinitis; Cys-L
A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma
Keywords: Clinical trials; Asthma; Non-invasive methodology; Airway inflammation; AHR; airway hyperresponsiveness; AMP; adenosine 5â² monophosphate; ASM; airway smooth muscle; ATS; American Thoracic Society; BAL; bronchoalveolar lavage; BPT; bronchoprovocation tes
In vitro expansion of long-term repopulating hematopoietic stem cells in the presence of immobilized Jagged-1 and early acting cytokines
Keywords: Jagged-1; Long-term repopulating ability stem cells; Notch signaling; Self-renewal; Serial BM transplantation; BFU-E; burst-forming units erythroid; BM; bone marrow; CFU-GM; colony-forming units granulocyte-macrophage; FL; Flk-2/Flt-3 ligand; HSC; hemat